CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SLATER, H. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SLATER, H. M.

Canadian Journal of Anesthesia, Vol 4, 5-12, Copyright © 1957 by Canadian Anesthesiologists' Society

The Use of Trifluoroethyl Vinyl Ether (Fluoromar®) in Anaesthesia for Dentistry

HARRY M. SLATER M.D.1

1 Montreal, Quebec

1. The pharmacologic properties of trifhioroethyl vinyl ether (Fluoromar®) are outlined.

2. Favourable clinical observations of Fluoromar in dentistry indicate its use as an adjuvant to nitrous oxide-oxygen analgesia and anaesthesia.

3. Statistical data are presented.

Note:

Fluoromar® was supplied by the Ohio Chemical and Surgical Equipment Company, a division of Air Reduction, Inc.

Presented at the Annual Meeting, Canadian Anaesthetists' Society, Mont Tremblant, Quebec, June 1956.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1957 by the Canadian Anesthesiologists' Society.